The hallmark genetic abnormality of CML is a chimeric BCR/ABL1 fusion gene resulting from the Philadelphia chromosome rearrangement t(9;22)(q34;q11). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.